Polymyalgia rheumatica natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
Polymyalgia rheumatica (PMR) affects the quality of life of the patients. The pain and stiffness in the proximal joints might lead to sleep disturbance as well as inability to do regular daily activities such as getting dressed and getting out of a chair. The symptoms begin rapidly and last for weeks. Once the [[steroid]] treatment is initiated, the symptoms resolve rapidly within few days. In fact, the rapid resolution of symptoms with the [[steroid]] therapy reinforces the diagnosis of PMR. The [[steroid]] treatment can be associated with complications such as [[weight gain]] and bone fracture.<ref name="pmid23051717">{{cite journal| author=Kermani TA, Warrington KJ| title=Polymyalgia rheumatica. | journal=Lancet | year= 2013 | volume= 381 | issue= 9860 | pages= 63-72 | pmid=23051717 | doi=10.1016/S0140-6736(12)60680-1 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23051717  }} </ref> Approximately 40 to 50% of subjects experience relapse of the symptoms. PMR is associated with [[giant cell arteritis]].
Polymyalgia rheumatica (PMR) affects the quality of life of the patients. The [[pain]] and stiffness in the proximal [[joints]] might lead to sleep disturbance as well as an inability to do regular daily activities such as getting dressed and getting out of a chair. The symptoms begin rapidly and last for weeks. Once the [[steroid]] treatment is initiated, the symptoms resolve rapidly within few days. In fact, the rapid resolution of symptoms with the [[steroid]] therapy reinforces the diagnosis of PMR. The [[steroid]] treatment can be associated with complications such as [[weight gain]] and [[bone fracture]]. Approximately 40 to 50% of subjects experience relapse of the symptoms. PMR is associated with [[giant cell arteritis]].


==Natural History==
==Natural History==
* If left untreated, PMR affects the quality of life of the patients.   
* If left untreated, PMR affects the quality of life of the patients.   
* The [[pain]] and stiffness in the proximal [[Joint|joints]] might lead to [[Sleep disorder|sleep disturbance]] as well as inability to do regular daily activities such as getting dressed and getting out of a chair.
* The [[pain]] and stiffness in the proximal [[Joint|joints]] might lead to [[Sleep disorder|sleep disturbance]] as well as an inability to do regular daily activities such as getting dressed and getting out of a chair.
* The symptoms begin rapidly and last for weeks.
* The symptoms begin rapidly and last for weeks.


Line 42: Line 42:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
 
[[Category:Medicine]]
{{WH}}
{{WS}}
[[Category:Disease]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Up-To-Date]]
[[Category:Primary care]]

Revision as of 18:01, 8 May 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Polymyalgia Rheumatica Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polymyalgia rheumatica from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polymyalgia rheumatica natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polymyalgia rheumatica natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polymyalgia rheumatica natural history, complications and prognosis

CDC on Polymyalgia rheumatica natural history, complications and prognosis

Polymyalgia rheumatica natural history, complications and prognosis in the news

Blogs on Polymyalgia rheumatica natural history, complications and prognosis

Directions to Hospitals Treating Polymyalgia rheumatica

Risk calculators and risk factors for Polymyalgia rheumatica natural history, complications and prognosis

Overview

Polymyalgia rheumatica (PMR) affects the quality of life of the patients. The pain and stiffness in the proximal joints might lead to sleep disturbance as well as an inability to do regular daily activities such as getting dressed and getting out of a chair. The symptoms begin rapidly and last for weeks. Once the steroid treatment is initiated, the symptoms resolve rapidly within few days. In fact, the rapid resolution of symptoms with the steroid therapy reinforces the diagnosis of PMR. The steroid treatment can be associated with complications such as weight gain and bone fracture. Approximately 40 to 50% of subjects experience relapse of the symptoms. PMR is associated with giant cell arteritis.

Natural History

  • If left untreated, PMR affects the quality of life of the patients.
  • The pain and stiffness in the proximal joints might lead to sleep disturbance as well as an inability to do regular daily activities such as getting dressed and getting out of a chair.
  • The symptoms begin rapidly and last for weeks.

Complications

Prognosis

  • Once the steroid treatment of PMR is initiated, the symptoms resolve rapidly within few days. In fact, the rapid resolution of symptoms with the steroid therapy reinforces the diagnosis of PMR.
  • Approximately 40 to 50% of subjects experience relapse of the symptoms, which requires longer duration of glucocorticoid treatment.[4]
  • Factors that are associated with relapse are:

References

  1. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG (1995). "The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern". Ann Intern Med. 123 (3): 192–4. PMID 7598301.
  2. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG (1995). "Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991". Arthritis Rheum. 38 (3): 369–73. PMID 7880191.
  3. Franzén P, Sutinen S, von Knorring J (1992). "Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988". J Rheumatol. 19 (2): 273–6. PMID 1629827.
  4. 4.0 4.1 4.2 Kermani TA, Warrington KJ (2013). "Polymyalgia rheumatica". Lancet. 381 (9860): 63–72. doi:10.1016/S0140-6736(12)60680-1. PMID 23051717.
  5. Mavrogeni S, Bratis K, Mavragani CP (2013). "Myocardial inflammation in polymyalgia rheumatica assessed using cardiac magnetic resonance imaging". Exp Clin Cardiol. 18 (2): 151–2. PMC 3718596. PMID 23940441.